← Browse by Condition
Medical Condition

egfr her2 exon 20 insertion mutation

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06043817 Phase 1, Phase 2
Recruiting

First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

Enrollment
251 pts
Location
United States, Franc...
Sponsor
Pierre Fabre Medicament
View Trial →